Enzymatica’s business is exposed to several risks, both operational and financial risks.

The operational risks mainly comprise uncertainty concerning product development, supplier agreements, regulatory permits, product liability and distribution, and in addition, sales as a consequence of the pandemic. The financial risks primarily consist of currency, interest, price, credit and liquidity risks.

For a more detailed description of the risks and uncertainties Enzymatica faces, please read in our Swedish annual report: